Jana Lisa van Luttikhuizen

The identification of pathogenic variants in <i>BRCA1/2</i> negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of <i>FANCM</i> pathogenic variants

Stephanie Schubert, Jana Lisa van Luttikhuizen, Bernd Auber et al. · International Journal of Cancer · 2018 · 86 citations · Full text

Breast Oncology, Genetics, Genetic Epidemiology +16

E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements

Matthias Christgen, Stephan Bartels, Jana Lisa van Luttikhuizen et al. · Modern Pathology · 2020 · 44 citations · Full text

Breast Oncology, P-cadherin Switching, Immunology +19

<i>CDKN2A</i> loss and <i>PIK3CA</i> mutation in myoepithelial‐like metaplastic breast cancer

Stephan Bartels, Jana Lisa van Luttikhuizen, Matthias Christgen et al. · The Journal of Pathology · 2018 · 34 citations

Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid‐papillary carcinoma

Matthias Christgen, Stephan Bartels, Jana Lisa van Luttikhuizen et al. · The Journal of Pathology Clinical Research · 2017 · 33 citations · Full text

Precise <i>ERBB2</i> copy number assessment in breast cancer by means of molecular inversion probe array analysis

Matthias Christgen, Jana Lisa van Luttikhuizen, Mieke Raap et al. · Oncotarget · 2016 · 10 citations · Full text